Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Toripalimab Maintenance in NK/T-cell Lymphoma
NCT04338282Phase 2Unknown
- Sponsor
- Beijing Tongren Hospital
- Start
- Jun 2020
- Primary completion
- May 2022
01
Overview
A Phase 2 trial of toripalimab in Extranodal NK/T-cell lymphoma nasal type (ENKTCL-NT), sponsored by Beijing Tongren Hospital. Status: unknown.
02
Drugs
toripalimab
03
Conditions
Extranodal NK/T-cell lymphoma nasal type (ENKTCL-NT)
Beyond the preview
Go deeper on NCT04338282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04338282.